Patents by Inventor Tryggve Holck STORÅS

Tryggve Holck STORÅS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Processing MRI data for analysis of tumors
    Patent number: 11138729
    Abstract: Dynamic contrast enhanced MRI data and dynamic susceptibility contrast MRI data for a volume of the patient's body including a tumor are used in order to identify the risk of lymph node metastasis. A volume of interest enclosing the tumor is identified and the MRI data for the volume of interest is processed in order to identify one or more parameters relating to the transverse relaxation rate and/or to dynamic changes in the transverse relaxation rate. A comparison is made to previously obtained similar parameters for other patients having similar tumors that are either known to exhibit lymph node metastasis or are known not to exhibit lymph node metastasis in order to determine if the MRI data indicates that the patient has a tumor at greater risk of exhibiting lymph node metastasis or a tumor with a lesser risk of exhibiting lymph node metastasis.
    Type: Grant
    Filed: April 20, 2017
    Date of Patent: October 5, 2021
    Assignees: OSLO UNIVERSITETSSYKEHUS HF, AKERSHUS UNIVERSITETSSYKEHUS HF
    Inventors: Kjell-Inge Gjesdal, Endre Grøvik, Kathrine Røe Redalen, Tryggve Holck Storås
  • PROCESSING MRI DATA FOR ANALYSIS OF TUMORS
    Publication number: 20190156479
    Abstract: Dynamic contrast enhanced MRI data and dynamic susceptibility contrast MRI data for a volume of the patient's body including a tumor are used in order to identify the risk of lymph node metastasis. A volume of interest enclosing the tumor is identified and the MRI data for the volume of interest is processed in order to identify one or more parameters relating to the transverse relaxation rate and/or to dynamic changes in the transverse relaxation rate. A comparison is made to previously obtained similar parameters for other patients having similar tumors that are either known to exhibit lymph node metastasis or are known not to exhibit lymph node metastasis in order to determine if the MRI data indicates that the patient has a tumor at greater risk of exhibiting lymph node metastasis or a tumor with a lesser risk of exhibiting lymph node metastasis.
    Type: Application
    Filed: April 20, 2017
    Publication date: May 23, 2019
    Inventors: Kjell-Inge GJESDAL, Endre GRØVIK, Kathrine Røe REDALEN, Tryggve Holck STORÅS